2
12
3
4

 

>
CASE STUDY 1
Parenteral dosage form development of a highly insoluble molecule
>
CASE STUDY 2
Salt form optimization and lyophilized parenteral formulation development
>
CASE STUDY 3
Oral liquid formulation development
>
CASE STUDY 4
Accelerated stability studies to support a screening IND
>
CASE STUDY 5
Lead Optimization: Solubility and formulation screen for efficacy and PK studies

 

Events and Speaking Engagements


2008 BIOPHARMA OUTSOURCING:
Partnership with CROs and Service Providers


Location
: Hilton Boston Back Bay • Boston, MA
Date: March 25-26, 2008
Topic: Local Outsourcing – Interactivity a Key Element in a Dynamic Environment
Speaker: Janet Wolfe, Ph.D., President, Wolfe Laboratories Inc.
Program: 2008 Biopharma Outsourcing

2008 Healthcare Businesswomen’s Association (HBA) Boston Chapter

Location: Simmons School of Management, Boston, MA
Date: April 3, 2008
Topic: Start-Up Companies: Behind the Scenes
Panel Speakers: Janet Wolfe, Ph.D., President, Wolfe Laboratories; Cyntia Fisher, CEO of BioMed 20/20 Technologies; Yael Schwartz, Ph.D., President of Hygeia Therapeutics; and Ellen Baron, Ph.D., Partner at Oxford Biosciences Partners.
Program: 2008 HBA Boston

Enhancing the Working Relationship with CROs by Using Project Management

Location: MBC Office, Cambridge, MA
Date: April 15, 2008
Topic: Enhancing the working relationship with CROs by using Project Management
Speakers:
Nicole Krilla, Wolfe Laboratories and James Rolke, Prospect Therapeutics
Program: Project Management Committee

MIT Sloan BioInnovations 2008 Conference

Location: MIT School of Management, Kendall Square, Cambridge, MA
Date: April 18, 2008
Topic: The first $10M -- going from bench to bedside.  Exploring the pathways and pitfalls to commercialization of technology in the life sciences
Panel Speakers: Janet Wolfe, Ph.D., President, Wolfe Laboratories; Michael Greeley, Managing Director, IDG Ventures; Kurt Dasse, CEO, Levitronix; Nicho Hatsopoulos, Ph.D., Hatsopoulos Lab at the University of Chicago; Bob Buderi, Founder, CEO and editor in chief of Xconomy
Program: BioInnovation 2008

Fundamentals of Solid Oral Dosage Formulation Development

This intensive 2-day course is designed to impart the tools and knowledge necessary to systemically approach the development of solid oral dosage formulations.  Taught by Dr. Shelley Rabel , Dr. Christopher Riley (Riley & Rabel Consulting Services), and Dr. Janet Wolfe (Founder & CEO of Wolfe Laboratories) who have over 40 years of combined experience in the development of solid oral dosage formulations for small molecule pharmaceuticals.
Click here to learn more.

Location:
Fisherman’s Wharf Hilton, San Francisco, CA
Date: April 24-25, 2008
and
Location: Back Bay Hilton, Boston, MA
Date: May 15-16, 2008

Fundamentals of Protein Pharmaceutical
Formulation Development


Wolfe Laboratories is sponsoring a short course on protein formulation development. The course will detail formulation development requirements within the context of each phase of the clinical development process—including an overview of protein structure, chemical and physical degradation pathways, protein analytical methods, protein formulation, stability, and characterization methods. Allow our experienced scientists to help you progress in your scientific endeavors in our historic locale. The two-day course will be taught by Dr. Bret Shirley (Stryker Biotech) and Dr. Janet Wolfe.  
Click here to learn more.

Location:
Fisherman’s Wharf Hilton, San Francisco, CA
Date: April 24-25, 2008
and
Location: Back Bay Hilton, Boston, MA
Date: May 15-16, 2008

AAPS Annual Meeting and Exposition

Organization: American Association of Pharmaceutical Scientists
Location: Atlanta, GA
Date: November 16-18, 2008
Program: Exhibition hall


Click here to see 2007 Events

 

 



 

© 2004 Wolfe Laboratories, Inc. All rights reserved.